Pasar al contenido principal

ESTUDIO METABOLOMICO DE LA INTERACCION HUESPED-MICROBIOTA INTESTINAL EN LA ENFERMEDAD CARDIOMETABOLICA. PAPEL EN DETECCION TEMPRANA, PREVENCION Y TRATAMIENTO.

SAF2014-52875-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2014
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Secretaría de Estado de Educación, Formación Profesional y Universidades
Centro beneficiario FUNDACION PARA LA INVESTIGACION DEL HOSPITAL CLINICO DE LA COMUNIDAD VALENCIANA (INCLIVA)
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Human breast milk NMR metabolomic profile across specific geographical locations and its association with the milk microbiota

  • Gómez-Gallego, Carlos
  • Morales, Jose Manuel
  • Monleón, Daniel
  • Du Toit, Elloise
  • Kumar, Himanshu
  • Linderborg, Kaisa M.
  • Zhang, Yumei
  • Yang, Baoru
  • Isolauri, Erika
  • Salminen, Seppo
  • Collado, María Carmen
The composition of human breast milk is highly variable, and it can be influenced by genetics, diet, lifestyle, and other environmental factors. This study aimed to investigate the impact of geographical location and mode of delivery on the nuclear magnetic resonance spectroscopy (NMR) metabolic profile of breast milk and its relationship with the milk microbiome. Human milk metabolic and microbiota profiles were determined using NMR and 16S rRNA gene sequencing, respectively, in 79 healthy women from Finland, Spain, South Africa, and China. Up to 68 metabolites, including amino acids, oligosaccharides, and fatty acid-associated metabolites, were identified in the milk NMR spectra. The metabolite profiles showed significant differences between geographical locations, with significant differences (p < 0.05) in the levels of galactose, lacto-N-fucopentaose III, lacto-N-fucopentaose I and 2-fucosyllactose, 3-fucosyllactose, lacto-N-difucohexaose II, lacto-N-fucopentaose III, 2-hydroxybutyrate, 3-hydroxybutyrate, proline, N-acetyl lysine, methyl-histidine, dimethylamine, kynurenine, urea, creatine and creatine phosphate, formate, lactate, acetate, phosphocholine, acetylcholine, LDL, VLDL, ethanolamine, riboflavin, hippurate, spermidine, spermine and uridine. Additionally, the effect of caesarean section on milk metabolome was dependent on the geographical region. Specific interrelations between human milk metabolites and microbiota were also identified. Proteobacteria, Actinobacteria, and Bacilli were most significantly associated with the milk metabolites, being either positively or negatively correlated depending on the metabolite. Our results reveal specific milk metabolomic profiles across geographical locations and also highlight the potential interactions between human milk’s metabolites and microbes., This work has been funded by the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (ERC Starting Grant, project no. 639226). DM gratefully acknowledges financial support from the JPI HDHL (GUTMOM project) and the Ministerio de Ciencia, Innovación y Universidades from Spain (PCIN-2017-117 and SAF2014-52875R), and also from the ‘Instituto de Salud Carlos III and co-funded by FEDER founds’ (grant number PIE15/00013)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Microbiome-metabolome signatures in mice genetically prone to develop dementia, fed a normal or fatty diet

  • Sanguinetti, Elena
  • Collado, María Carmen
  • Marrachelli, Vannina G.
  • Monleón, Daniel
  • Selma Royo, Marta
  • Pardo Tendero, M.M.
  • Burchielli, S.
  • Iozzo, P.
Cognitive decline, obesity and gut dysfunction or microbial dysbiosis occur in association. Our aim was to identify gut microbiota-metabolomics signatures preceding dementia in genetically prone (3xtg) mice, with and without superimposed high-fat diet. We examined the composition and diversity of their gut microbiota, and serum and faecal metabolites. 3xtg mice showed brain hypometabolism typical of pre-demented stage, and lacked the physiological bacterial diversity between caecum and colon seen in controls. Cluster analyses revealed distinct profiles of microbiota, and serum and fecal metabolome across groups. Elevation in Firmicutes-to-Bacteroidetes abundance, and exclusive presence of Turicibacteraceae, Christensenellaceae, Anaeroplasmataceae and Ruminococcaceae, and lack of Bifidobacteriaceae, were also observed. Metabolome analysis revealed a deficiency in unsaturated fatty acids and choline, and an overabundance in ketone bodies, lactate, amino acids, TMA and TMAO in 3xtg mice, with additive effects of high-fat diet. These metabolic alterations were correlated with high prevalence of Enterococcaceae, Staphylococcus, Roseburia, Coprobacillus and Dorea, and low prevalence of S24.7, rc4.4 and Bifidobacterium, which in turn related to cognitive impairment and cerebral hypometabolism. Our results indicate an effect of transgenic background on gut microbiome-metabolome, enhanced by high-fat diet. The resulting profiles may precede overt cognitive impairment, suggesting their predictive or risk-stratifying potential., This work was supported by the Ministry of Economy, Industry and Competitiveness of Spain (MINECO-Spanish Government, grant numbers SAF2014–52875R to DM, and AGL2015–707487-P to MCC), Instituto de Salud Carlos III and co-funded by ‘FEDER’ (grant number PIE15/00013 to DM), and the European DORIAN-Health-FP7 project (GA 278603 to PI)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Two-Week Aflibercept or Erlotinib Administration Does Not Induce Changes in Intestinal Morphology in Male Sprague–Dawley Rats But Aflibercept Affects Serum and Urine Metabolic Profiles

  • Forsgård, Richard A.
  • Marrachelli, Vannina G.
  • Lindén, Jere
  • Frías, Rafael
  • Collado, María Carmen
  • Korpela, Riitta
  • Monleón, Daniel
  • Spillmann, Thomas
  • Österlund, Pia
Gastrointestinal toxicity is a frequently observed adverse event during cancer treatment with traditional chemotherapeutics. Currently, traditional chemotherapeutics are often combined with targeted biologic agents. These biologics, however, possess a distinct toxicity profile, and they may also exacerbate the adverse effects of traditional chemotherapeutics. In this study, we aimed to characterize the gastrointestinal and metabolic changes after a 2-week treatment period with aflibercept, an antiangiogenic VEGFR decoy, and with erlotinib, a tyrosine-kinase inhibitor. Male rats were treated either with aflibercept or erlotinib for 2 weeks. During the 2-week treatment period, the animals in the aflibercept group received two subcutaneous doses of 25 mg/kg aflibercept. The erlotinib group got 10 mg/kg of erlotinib by oral gavage every other day. The control groups were treated similarly but received either saline injections or oral gavage of water. Intestinal toxicity was assessed by measuring intestinal permeability and by histological analyses of intestinal tissues. Metabolic changes were measured with H nuclear magnetic resonance in serum and urine. Neither aflibercept nor erlotinib induced changes in intestinal permeability or intestinal tissue morphology. However, aflibercept treatment resulted in stunted body weight gain and altered choline, amino acid, and lipid metabolism. Two-week treatment with aflibercept or erlotinib alone does not induce observable changes in gastrointestinal morphology and function. However, observed aflibercept-treatment related metabolic changes suggest alterations in intestinal microbiota, nutrient intake, and adipose tissue function. The metabolic changes are also interesting in respect to the systemic effects of aflibercept and their possible associations with adverse events caused by aflibercept administration., The study received funding from the Cancer Society of Finland, Finska Läkaresällskapet, Foundation of Clinical Chemistry Research, and Biomedicum Helsinki Foundation. We gratefully acknowledge the Ministry of Economy and Competitiveness of Spain (SAF2014-52875R) and Instituto de Salud Carlos III and FEDER (grant number PIE15/00013) for co-funding the study. We also gratefully acknowledge the Ministry of Science, Innovation and Universities (PCIN-2017-117) and the EU Joint Programming Initiative ‘A Healthy Diet for a Healthy Life’ (JPI HDHL INTIMIC-085). M. C. C. would like to acknowledge the support of the Spanish Government of Economy and Competitiveness (MINECO, ref. AGL2015-707487-P).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Magnetic resonance microscopy and correlative histopathology of the infarcted heart

  • Perez-Terol, Itziar
  • Rios-Navarro, César
  • de Dios, Elena
  • Morales, José Manuel|||0000-0002-4404-6735
  • Gavara Doñate, Jose|||0000-0002-3483-7066
  • Perez-Sole, Nerea
  • Diaz, Ana
  • Minana, Gema
  • Segura-Sabater, Remedios
  • Bonanad, Clara
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Husser, Oliver
  • Monmeneu, José V.
  • Lopez-Lereu, María P.
  • Núñez, Julio|||0000-0003-1672-7119
  • Chorro, Francisco J.
  • Ruiz-Sauri, Amparo
  • Bodi, Vicente|||0000-0001-6425-5828
  • Monleon, Daniel|||0000-0002-4803-1573
Delayed enhancement cardiovascular magnetic resonance (MR) is the gold-standard for non-invasive assessment after myocardial infarction (MI). MR microscopy (MRM) provides a level of detail comparable to the macro objective of light microscopy. We used MRM and correlative histopathology to identify infarct and remote tissue in contrast agent-free multi-sequence MRM in swine MI hearts. One control group (n = 3 swine) and two experimental MI groups were formed: 90 min of ischemia followed by 1 week (acute MI = 6 swine) or 1 month (chronic MI = 5 swine) reperfusion. Representative samples of each heart were analysed by contrast agent-free multi-sequence (T1-weighting, T2-weighting, T2*-weighting, T2-mapping, and T2*-mapping). MRM was performed in a 14-Tesla vertical axis imager (Bruker-AVANCE 600 system). Images from MRM and the corresponding histopathological stained samples revealed differences in signal intensities between infarct and remote areas in both MI groups (p-value < 0.001). The multivariable models allowed us to precisely classify regions of interest (acute MI: specificity 92% and sensitivity 80%; chronic MI: specificity 100% and sensitivity 98%). Probabilistic maps based on MRM images clearly delineated the infarcted regions. As a proof of concept, these results illustrate the potential of MRM with correlative histopathology as a platform for exploring novel contrast agent-free MR biomarkers after MI.